Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb pilot study of GSK1349572 in ART-experienced HIV-1 adults with raltegravir resistance
2009-010270-37Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by GSK. Primary endpoint: Primary antiviral response at Day 11. Started Jul 2009; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-010270-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010270-37.